Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis
- PMID: 30150366
- DOI: 10.1136/annrheumdis-2018-214191
Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis
Keywords: cytokines; disease activity; systemic vasculitis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis' by Liebling et al.Ann Rheum Dis. 2019 Oct;78(10):e117. doi: 10.1136/annrheumdis-2018-214239. Epub 2018 Oct 3. Ann Rheum Dis. 2019. PMID: 30282669 No abstract available.
Comment on
-
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).Ann Rheum Dis. 2018 Mar;77(3):348-354. doi: 10.1136/annrheumdis-2017-211878. Epub 2017 Nov 30. Ann Rheum Dis. 2018. PMID: 29191819 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
